Financial Gravity Asset Management, Inc.

Position in LLY — ELI LILLY & Co

CIK 1741736 Lakeway, TX

Position in LLY

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$45,068

+$2,081 QoQ

Shares Held

+22.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Financial Gravity Asset Management, Inc. holds $16,585,205 across 10 Drug Manufacturers - General names. LLY ranks #7 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG	47,971	$7,327,570
2	JNJ	Johnson & Johnson	15,272	$3,733,087
3	AZN	Astrazeneca PLC	16,601	$3,274,049
4	NVO	Novo Nordisk A S	51,858	$1,905,781
5	GILD	Gilead Sciences, Inc.	1,478	$205,988
6	ABBV	AbbVie Inc.	336	$73,076
7	LLY	ELI LILLY & Co This page	49	$45,068
8	MRK	Merck & Co., Inc.	100	$12,029

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$45,068	49	+22.5%	Shares	Sole	2026-05-08
2025-12-31	$42,987	40	-40.3%	Shares	Sole	2026-02-13
2025-09-30	$51,121	67	+39.6%	Shares	Sole	2025-11-14
2025-03-31	$39,643	48	0.0%	Shares	Sole	2025-04-30
2024-03-31	$37,342	48	0.0%	Shares	Sole	2024-06-26
2023-12-31	$27,980	48	+1100.0%	Shares	Sole	2024-06-26
2023-09-30	$2,148	4	-99.1%	Shares	Sole	2023-11-16
2023-06-30	$9,014	469	+36.7%	Shares	Sole	2023-08-09
2023-03-31	$44	343	-6.3%	Shares	Sole	2023-05-12
2022-12-31	$8,207	366	-77.3%	Shares	Sole	2023-02-15
2022-09-30	$21,000	1,615	-78.3%	Shares	Sole	2022-11-03
2022-06-30	$1,733,800	7,452	+421.1%	Shares	Sole	2022-08-05
2022-03-31	$22,000	1,430	-79.3%	Shares	Sole	2022-05-13
2021-12-31	$1,841,664	6,900	+45900.0%	Shares	Sole	2022-02-11
2021-03-31	$2,802	15	+650.0%	Shares	Sole	2021-05-17
2020-12-31	$337	2	-98.3%	Shares	Sole	2021-02-16
2020-03-31	$15,952	115	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.